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Abstract  
Enantioselective construction of nitrogen-substituted quaternary carbon centers adjacent to 
the carbonyl group in the cyclohexane ring was performed with respect to the asymmetric 
synthesis of anesthetic (S)-ketamine 1.  Diastereoselective nucleophilic 1,2-addition 
reaction of phenyllithium to α-ketoxime-ether acetal 9 bearing chiral auxiliary on the 
α-carbonyl function gave benzyloxyamine 11 major in 83% yield with 82% de, which was 
converted to the corresponding amino ketone 12.  However, the reaction of 
2-chlorophenyllithium did not work in which this route was unavailable for the synthesis of 
1.  Then, an alternative strategy directed toward 1, starting with a compound having 
2-chlorophenyl groups in advance, was designed so that the chiral quaternary carbon center 
bearing a nitrogen atom in the ring is created by the enantioselective reduction of the 
atropisomeric intermediate ketone 18, and the sequential allyl cyanate-to-isocyanate 
rearrangement with complete 1,3-chirality transfer.  The first asymmetric synthesis of 1 
with excellent selectivity (>99% ee) was accomplished by a short path according to the 
strategy. 
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1.  Introduction 
 
Ketamine 1, 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone, has been widely used as 
an anesthetic and analgesic in human and veterinary medicine under the trade name Ketalar 
since 1963.1  The racemic ketamine 1 was prepared by Stevens through thermal 
isomerization of 1-[(2-chlorophenyl)(methylimino)methyl]-cyclopentanol.2-5  The 
commercially available ketamine is a racemic mixture of two enantiomers (Chart 1).  The 
(S)-enantiomer is shown to be more potent with an approximately 3-4 fold anesthetic 
potency compared to (R)-one: this correlates to the higher binding affinity for the PCP-site 
of the NMDA-receptor and only (R)-1 is responsible for agitation, hallucination, and 
restlessness in contrast to (S)-1.6  The more active (S)-1 has been increasing in 
commercially available preparations.  However, the enantiopure compound is only 
obtained via optical resolution of the tartaric acid salt,7 leaving the undesired (R)-1 as a 
by-product.  Therefore, development of an asymmetric synthesis for the (S)-enantiomer is 
highly desirable.  Recently, Brunner challenged an asymmetric rearrangement of 
1-[(2-chlorophenyl)(methylimino)methyl]-cyclopentanol to optically active ketamine 1 with 
2-[4-(S)-tert-butyloxazolin-2-yl]-pyridine coordinated Ni complexes but unfortunately the 
attempt resulted in failure, only giving a racemic product.8  To the best of our knowledge, 
no successful synthesis of (S)-1 has been reported. 
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On the other hand, a challenging methodology in organic synthesis prompted us to develop 
the enantioselective construction of quaternary carbon centers bearing a nitrogen atom, 
which are ubiquitous in naturally occurring pharmaceutical drugs (e. g., alkaloids),9 but 
effective approaches are quite limited.10  The difficulty on the case of (S)-1 can be ascribed 
in part to the special requisite that the nitrogen-substituted quaternary carbon has an aryl 
group from the carbon and a carbonyl group adjacent to the carbon in the ring system.  As 
part of our ongoing project to find a new reliable route to (S)-1, we applied a straightforward 
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methodology, utilizing nucleophilic 1,2-addition to chiral α-ketoxime-ether acetals.  The 
enantioselective 1,2-addition reaction of phenyllithium to the chiral imines proceeded with 
considerably high diastereoselectivity.  After deprotection, the asymmetric synthesis of the 
chiral model compound was established.  However, the reaction of 2-chlorophenyllithium 
did not work so that the method could not lead to the asymmetric synthesis of (S)-1.  Then, 
we employed the plan using an allyl cyanate-to-isocyanate rearrangement (Scheme 1), 
recently developed by Ichikawa,11 independent of the rearrangement developed by Stevens.2  
The strategy, with a combination of an enantioselective reduction and the rearrangement 
provided a novel and short route directed toward (S)-ketamine 1.  We describe herein the 
details of the foregoing 1,2-addition to chiral imines and disclose the first asymmetric 
synthesis of (S)-1 by the sequential enantioselective reduction-rearrangement strategy. 
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Scheme 1.  1,3-Chirality transfer via allyl cyanate-to-isocyanate rearrangement
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2.  Results and discussion  
 
2.1.  Enantioselective construction of quaternary carbon centers bearing a nitrogen 
atom by nucleophilic 1,2-addition to chiral α-ketoxime-ether acetals   
 
Whereas chiral quaternary carbon centers have been generally realized by the asymmetric 
addition of nucleophiles to ketones, the enantioselective construction of nitrogen-substituted 
quaternary carbon centers by the straightforward addition to ketimines is regarded to be 
more difficult because of the poor electrophilic characteristic of ketimines in comparison 
with that of ketones.12  As a model of simple routes to (S)-1, we considered employing 
nucleophilic addition of RM reagents to N-methylketimines, directly affording the 
N-methylamine function necessary for 1.  After some preliminary studies, however, 
N-methylketimines turned out to be inadequate for the purpose because of their inherent 
instability.  Then, the related ketoxime ethers were chosen as the starting electrophiles, 
which have the higher stability toward hydrolysis and can be efficiently purified by 
silica-gel column chromatography.  While there are limited examples of the addition of 
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organometallic reagents to chiral open-chain ketoxime ethers,13,14 no example for the 
addition to cyclic ketoxime ethers has been reported.  Thus, diastereoselective nucleophilic 
1,2-addition reactions were designed to the ketoxime ethers modified the α-carbonyl group 
with chiral diol auxiliaries, as depicted in Scheme 2.   
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Scheme 2.  Diastereoselective addition with chiral auxiliaries
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The availability of the chiral diol auxiliary has been reported15 for the Grignard addition 
reactions to a chiral α-keto acetal and to a chiral α-aldoxime-ether acetal in the presence of 
CeCl3.  However, the utilization of such a chiral auxiliary has not been reported for the 
enantioselective addition to ketimines with regard to the asymmetric construction of 
nitrogen-substituted quaternary carbon centers.  We chose C2-symmetric diols, 
(-)-(2R,3R)-2,3-butanediol 5 and (-)-(2S,3S)-1,4-dimethoxy-2,3-butanediol 6, suitable for 
our purposes.  Chiral α-ketoxime-ether acetals 9 and 10 were prepared via the 
corresponding 7 and 8, as shown in Scheme 3. 
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Scheme 4.   Diastereoselective addition of phenyllithium to α-chiral ketoxime-ether acetals
 
 
The results of the diastereoselective addition are shown in Scheme 4.  The reaction of 
α-ketoxime-ether acetal 9 with PhLi proceeded well in toluene (−78ºC/ 1 h and then −17ºC/ 
1 h) to afford a diastereomeric mixture 11 in 83% yield.  A diastereoselectivity of 82% was 
determined using the methyl proton signals of the relative acetal moieties in the 1H-NMR 
spectra.  After separation using silica-gel column chromatography, the 11 major was 
subjected to acid hydrolysis with HCl to afford amino ketone 12 in a quantitative yield.  
The enantioselectivity of 12 was confirmed to be 82% ee by using HPLC with a DAICEL 
CHIRALPAK IA column (mobile phase: n-hexane/dichloromethane/diethylamine = 
90/10/0.1, retention times: 19 min for S and 27 min for R under a flow rate of 1.0 mL/min).  
Determination of the absolute configuration of the stereogenic center in 11 major using 
NMR spectroscopy techniques was quite difficult because of its quaternary carbon.  Then, 
using fine crystals recrystallized from n-hexane, the absolute configuration of the chiral 
center was determined to be R by X-ray diffraction analysis,16 as shown in Figure 1.   
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Figure 1.  ORTEP drawing of 11 major  
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In the result, it was shown that the (R,R)-chiral acetal auxiliary induces (R)-configuration at 
the newly created stereocenter.  A stable conformer of the encountered complex, comprised 
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of 9 and phenyllithium, was optimized by the calculation at the Density Functional Theory 
B3LYP/6-31G* level: all computations have been done using the GAUSSIAN 03 code, 
98,17 as shown in Figure 2.  The trajectory of the phenyl anion responsible for the resulting 
(R)-configuration can be explained with its approach to the upper site of the C=N double 
bond so as to avoid the steric hindrance induced by the coordinated phenyllithium.  On the 
other hand, the reaction of 10 with phenyllithium also proceeded with nearly the same de 
but the yield was comparatively low presumably owing to the excessive steric bulkiness of 
the acetal moiety bearing additional methoxy groups. 
 
Scheme 5.   Difficult 1,2-addition of 2-chlorophenyllithium to 9
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Unexpectedly, the 1,2-addition reaction of chiral α-ketoxime-ether acetal 9 with 
2-chlorophenyllithium, prepared from 2-bromochlorobenzene with n-butyllithium in THF at 
−78ºC,18 did not proceed because of the increased steric hindrance arising from the 
ortho-chloro substituent of the nucleophile (Scheme 5).  The addition of BF3·OEt219 could 
not apparently improve the addition reaction.  This method, based on the enantioselective 
construction of nitrogen-substituted quaternary carbon centers by the straightforward 
addition to chiral α-ketoxime-ether acetals, was conclusively found to be less promising for 
the asymmetric synthesis of (S)-ketamine 1. 
 
 
2.2.  Asymmetric synthesis of (S)-ketamine by the strategy of enantioselective 
reduction and sequential allyl cyanate-to-isocyanate rearrangement  
 
2.2.1.  Synthetic strategy directed toward (S)-1 and preparation of synthetic 
intermediate ketone 18 
 
As appeared in the Stevens’ first synthesis of racemic ketamine, it looks promising to utilize 
a rearrangement reaction for constructing such a structure with highly converged steric 
features.  Recently, Ichikawa et al. have presented the validity of applying allyl 
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cyanate-to-isocyanate rearrangement to the construction of quaternary carbon centers 
bearing a nitrogen atom.20  They confirmed, through the adaptation to acyclic systems, that 
the [1,3]-chirality transfer in the rearrangement takes place in a stereospecific manner 
without any scrambling at the stereogenic centers.  The efficiency of the rearrangement 
persuaded us to adapt it in an effective and novel route directed toward (S)-ketamine 1, as 
shown in Scheme 6.  The retrosynthesis of (S)-1 revealed that ketone 18 is suitable as a 
starting material.  As outlined in Scheme 7, the synthetic intermediate 18 was prepared 
from ethyl (2-chlorobenzoyl)acetate 14,21 according to Fleming’s procedure.22 
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Scheme 7.  Synthesis of synthetic intermediate ketone 18
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reflux, 3 h, 82%.
14 15
16 17 18
 
 
2.2.2.  Atropisomerism on alcohol 19 
 
Before choosing an appropriate enantioselective reduction of ketone 18, we prepared 
racemic alcohol 19 by lithium aluminum hydride reduction as a standard sample for chiral 
HPLC analysis to check the selectivity of the following enantioselective reduction.  The 
reduction of 18 in diethyl ether or THF occurred without any problems at room temperature 
under usual conditions but the product was found to be a mixture of diastereomers.  The 
appearance of the diastereoisomers is attributable to a new stereocenter induced by an 
atropisomerism23 resulting from hindered rotation about the single bond between the 
ortho-substituted phenyl and cyclohexene rings, which were related to (MP,RS)-19 
((aRaS,RS)-19) and (MP,SR)-19 ((aRaS,SR)-19),24 as represented in Scheme 8.  The 
diastereoisomers had a ratio of almost 1 to 1, which was estimated from the two doublet 
peaks corresponding to the methyl groups in the 1H-NMR spectra.  The ratio suggests that 
the reaction stereochemistry in the reduction was scarcely affected by the direction of the 
ortho-chloro substituent.  Unfortunately, the diastereoisomers could not be separated to 
each pure state where the interconversion of them took place under the conditions of 
silca-gel column chromatography.   It has become apparent that the steric hindrance to 
rotate could be considerably low for the isolation of the diastereoisomers.   
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Scheme 8.  Preparation of racemic alcohols 19
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The phenomenon of the interconversion was confirmed by HPLC measurement through the 
interaction of the four enantiomers with the chiral material packed in the column: the four 
peaks were observed in the chromatogram of a DAICEL CHIRALCEL OD-H.  Excessive 
overlaps were observed in their peaks between I and IV and between II and III, respectively 
(Figure 3).  These two pairs correspond to each distinguishable epimerization on 
atropisomerism, where the assignment of the structures; P-S, M-S, M-R, and P-R, to the 
corresponding peaks remains unclear at this stage.  We observed an additional interesting 
finding with regard to the partial epimerization on the atropic axis that a diastereomer 
isomerized toward the more stable another diastereomer in a ratio of 5 to 1 after standing in 
the solid state at room temperature for two months.25  The ideal rotational barrier on the 
atropisomers and the related structures were investigated by the Density Functional Theory, 
as mentioned above.17  The results are illustrated in Figure 4.  The calculation of the 
potential energy was performed every 10 degrees along the dihedral angle around the atropic 
axis.  Two stable structures of A and B were optimized: A was more stable than B by 4.7 
kcal/mol, where in A the ortho-chloro substituent and the alcohol moiety were situated at 
opposite side (anti) and the reverse was found for B (syn).  The rotational energy barrier 
was 22.8 kcal/mol.   
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DAICEL CHIRALCEL OD-H
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Flow rate:   1 mL/min
Detection:   UV 254 nm
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Figure 3.  Epimerization on diastereomeric atropisomers 19  
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Figure 4.  Rotaional barrier and optimized structures of atropisomers 
(B3LYP/6-31G* Level)
B (syn): (M,S)- or (P,R)-19 A (anti): (P,S)- or (M,R)-19
 
 
As a result, the enantiomeric purity of the product alcohol obtained in the expected 
enantioselective reduction could not be directly determined.  Then, in order to enable the 
determination of the enantioselectivity by preventing the rotation, the resulting racemic 
alcohols 19 were transformed into the corresponding benzoyl derivatives 20 in almost 
quantitative yields; the mixture of 20 showed only one spot on the TLC, and the two 
isomers could not be separated by silica gel-column chromatography.  By the 1H NMR 
measurement, the isomeric ratio (2.66 : 1) of 20 was found to be changed from the original 
ratio (1 : ~1) of 19, which is presumably due to the isomerization during the process of 
benzoylation.  The more stable isomer of 20 was confirmed to be anti by the calculation 
study.  However, the interconversion between the two atropisomers of 20 was found to be 
surely restricted due to the steric bulkiness of the introduced benzoyl group by checking 
their chromatogram of a DICEL CHIRALPAK IA column (mobile phase: n-hexane, 
retention times: 6 min for (P,S)-20 and 7 min for (M,R)-20 and 10 min for (M,S)-20 and 14 
min for (P,R)-20 under flow rate of 2.0 mL/min), in which the ratios of two diastereoisomers 
were observed to be almost the same as those of NMR (Figure 5). 
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2.2.3.  Chirality introduction by enantioselective reduction 
 
On the basis of the above results, we next focused our attention on the enantioselective 
reduction of ketone (MP)-18.  Our first choice for the enantioselective reduction was the 
Noyori’s classical BINAL-H reduction,26 which is known to be effective for α,β-olefinic 
ketones.  Considering the concerted six-membered cyclic transition state of 1,3-chirality 
transfer in the subsequent rearrangement, we were aware that (S)-configuration is necessary 
for alcohol 19 for the asymmetric synthesis of (S)-1, and therefore (S)-BINAL-H is a 
suitable reagent.  Treatment of 18 with (S)-BINAL-H in THF at −100 ºC resulted in the 
production of atropisomeric alcohols 19 in 85% yield, as shown in Scheme 9.  The 
resulting alcohols were transferred into the corresponding benzoyl derivatives 20 in a 
quantitative yield in order to determine the enantioselectivity of the reduction.  Judging 
from the methyl signals of the 1H NMR spectra of 20, the diastereomeric ratio was 
determined to be 1.93 : 1.  Needless to say, the change of the ratio can be ascribed to the 
epimerization on the atropisomerism during the benzoylation process.  Determination of 
the enantiomeric purity was performed by chiral HPLC analysis using a mixture of 20, as 
shown in Figure 5.  By direct comparison with an authentic chromatogram of the 
racemates, the major pair (A and C) and the minor pair (B and D) of the diastereisomers 
turned out to have 96% ee of (S)-isomer and >99% ee of (S)-isomer, respectively.  As a 
whole, the total enantioselectivity in the (S)-BINAL-H reduction of 18 was calculated to be 
97% ee.  This excellent enantioselection suggests that the newly created chiral center is 
almost completely controlled by the chirality of the catalyst,27 regardless of the 
stereochemistry of the substrate ketone concerned with the atropisomeric ortho-chloro 
substituent.  In addition, we explored Noyori’s ruthenium-catalyzed asymmetric transfer 
hydrogenation28 of 18 as a more practical catalytic method.  
[(1R,2R)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine]-(p-cymene)ruthenium(II), 
Ru[(R,R)-Ts-DPEN](p-cymene), served as an efficient catalyst for the enantioselective 
reduction of 18 to (S)-alcohol in a 5 to 2 formic acid-triethylamine azeotropic mixture at 40 
ºC.  The enantioselectivity of the conversion, however, was not excellent (77% ee).  
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Scheme 9.  Stoichiometric and catalytic "Noyori" enantioselective reductions of 
ketone 18
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Figure 5.  Determination (97% ee of S) of enantioselectivity by a chiral HPLC 
method with the benzoates 20 derived from the alcohols 19, obtained in 
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2.2.4.  Completion of asymmetric synthesis of (S)-ketamine. 
 
The reaction sequence from the diastereomeric optically active alcohols (MP,S)-19 to 
(S)-ketamine 1 is as follows (Scheme 10).  Reaction of 19 with trichloroacetyl isocyanate 
in dichloromethane at 0 ºC and subsequent hydrolysis with potassium carbonate in an 
aqueous methanol provided carbamate (MP,S)-21 in 96% yield.  The carbamate 21 was 
also a diastereomeric mixture of the atropisomers and without further purification was 
employed as a precursor to the cyanates, (P,S)-22 and (M,S)-22, for the successive allyl 
cyanate-to-isocyanate rearrangement.  According to Ichikawa’s procedure,11, 20 dehydration 
of 21 was carried out with triphenylphosphine, carbon tetrabromide, and triethylamine at 0 
ºC for 20 min as to provide the transient allyl cyanate.  During the one-pot procedure, the 
expected sigmatropic rearrangement took place to convert 22 to the corresponding 
isocyanate (R)-23.  Fortunately, the isocyanate was quite stable for the isolation process 
using an aqueous work-up and isolated as a single isomer in 98% yield.  The stability of 23 
is ascribed to its clearly inherent sterically hindered structure.  This easy isolation of 23 led 
to a shortening of the reaction path to the methyl amine moiety necessary for ketamine. In 
practice, treatment of 23 with lithium aluminum hydride in THF provided the methyl amine 
(R)-24 in 92% yield. 
 
The final stage toward ketamine is only the conversion of the functional group from the 
double bond to the carbonyl group.  Ozonolysis of 24 in dichloromethane at −18 ºC 
followed by a reductive work-up with dimethyl sulfide resulted in a miserable mixture.  
Presumably, the participation of the basic allylic amino function to the intermediate ozonide 
might have disturbed the normal ozonolysis.  Then, the hydrogen chloride salt of 24 was 
furnished for the ozonolysis in methanol.  Expectedly, the reaction proceeded smoothly to 
give the final product of 1, as the hydrogen chloride salt which was crystallized from 
ethanol-n-hexane in 95% yield.  The synthetic ketamine 1 was determined to be >99% ee 
with the almost complete enantiomeric purity of the (S)-configuration by chiral HPLC 
analysis, as illustrated in Figure 6.  Here, the first asymmetric synthesis of (S)-ketamine 
has been accomplished via a short path with excellent selectivity.  On the basis of the 
production of (S)-1 in maintaining the level of the chirality of the starting alcohol 19, the 
1,3-chirality transfer in the [3,3]-sigmatropic rearrangement was reevaluated to be 
stereospecific with the concerted mechanism via the six-membered cyclic transition state in 
this investigation.  Optically pure (R)-ketamine was also synthesized by starting with 
(R)-alcohol 19 from the enantioselective reduction of ketone 18 with (R)-BINAL-H. 
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Scheme 10.  Completion of asymmetric synthesis of (S)-ketamine via 
rearrangement
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oC, 98%; (c) LiAlH4, THF, 92%; (d) O3, CH2Cl2, 50 min, Me2S; (e) O3, 
MeOH, 50 min, Me2S, 95%.
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Figure 6.  Determination of enantiopurity of synthetic (S)-ketamine
DAICEL CHIRALCEL OD-H
Mobile phase:   5% 2-propanol/n-hexane
Flow rate:   0.5 mL/min
Detection:   UV 254 nm
racemic Ketamine (S)-Ketamine
 
 
 
3.  Conclusion 
 
The enantioselective construction of nitrogen-substituted quaternary carbon centers in the 
ring like (S)-ketamine was a very difficult challenge.  First, we have established a 
straightforward method for the construction of a chiral nitrogen-substituted quaternary 
carbon center using an enantioselective 1,2-addition reaction of phenyllithium to chiral 
α-ketoxime-ether acetals, 9 and 10, having α-chiral acetal auxiliary.  After deprotection, 
the approach provided the chiral compound with a nitrogen-substituted quaternary carbon 
bearing α-carbonyl group.  However, the reaction of 2-chlorophenyllithium did not work 
so that this route was unavailable for the synthesis of (S)-ketamine 1.  An alternative 
strategy was adapted to the synthesis, consisting of the enantioselective reduction of the 
atropisomeric intermediate ketone 18 and the sequential allyl cyanate-to-isocyanate 
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rearrangement with 1,3-chirality transfer.  The enantioselective reduction using 
(S)-BINAL-H gave (S)-alcohol 19 with 97% ee.  Subsequently, the complete 1,3-chirality 
transfer of the carbamate 21, derived from the alcohol, was observed to afford the 
corresponding isocyanate 23 in the [3,3]-sigmatropic allyl cyanate-to-isocyanate 
rearrangement.  Thus, the first asymmetric synthesis of (S)-ketamine 1, after reduction and 
ozonolysis, was accomplished with excellent selectivity (>99% ee).  
 
 
4.  Experimental  
 
4.1.  General 
 
All reactions unless otherwise noted were carried out under an argon atmosphere.  Flash 
column chromatography was carried out using Merck 60 silica-gel (230-400 mesh).  
Unless otherwise noted, all infrared spectra (IR) are reported in wave number (cm-1).  1H 
and 13C NMR spectra are reported; chemical shifts are expressed in ppm relative to internal 
standard tetramethylsilane (coupling constants: Hz).  High resolution mass spectra 
(HRMS) are reported in m/z. 
 
4.2.  Synthesis of ketones having an acetal moiety  
 
A solution of 1,2-cyclohexanedione (22.4 mmol, 2.51 g) and diol (22.4 mmol) in benzene 
(30 mL) was refluxed overnight with p-TsOH (8 mg) under a Dean-Stark water separator.  
Ether (30 mL) was added and unchanged diketone was extracted with 10% NaOH (aq) (15 
mL).  The organic layer was washed with brine and dried over anhydrous Na2SO4, and the 
solvent was evaporated.  The residual oil was purified by flash column chromatography on 
silica-gel. 
 
4.2.1.  2-Oxocyclohexanone (1R,2R)-1,2-dimethylethylene acetal (7)   
Colorless oil; (3.62 g, 88%): [α]D22 15.0 (c 1.00, CHCl3); IR (neat): 2972, 2870, 1735 cm-1; 
1H NMR (400 MHz, CDCl3) δ 1.23 (3H, d, J = 7.3), 1.28 (3H, d, J = 7.3), 1.82-1.97 (6H, m), 
2.48-2.54 (1H, m), 2.58-2.62 (1H, m), 3.61-3.73 (2H, m); 13C NMR (100 MHz, CDCl3) δ 
16.0, 16.4, 22.2, 25.9, 37.6, 39.2, 78.6, 78.7, 105.7, 206.0. 
 
4.2.2.  2-Oxocyclohexanone (1S,2S)-1,2-dimethoxyethylene acetal (8)   
Colorless oil; (4.45 g, 80%): [α]D22 −29.0 (c 1.00, CHCl3); IR (neat) 2939, 1736 cm-1; 1H 
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NMR (400 MHz, CDCl3) δ 1.70-1.79 (1H, m), 1.80-1.92 (3H, m), 1.95-2.05 (2H, m), 
2.48-2.55 (1H, m), 2.59-2.67 (1H, m), 3.37 (3H, s), 3.40 (3H, s), 3.43 (1H, d, J = 4.4), 
3.51-3.56 (3H, m), 4.01-4.05 (2H, m);  13C NMR (100 MHz, CDCl3) δ 22.6, 26.4, 37.9, 
39.7, 59.3, 59.5, 72.4, 73.2, 77.8, 78.5, 107.9, 206.8. 
 
4.3.  Synthesis of α-ketoxime-ether acetals  
 
To a solution of ketone (10.2 mmol) in MeOH (30 mL) were added HCl·H2NOCH2Ph (10.2 
mmol, 1.63 g) and pyridine (30.6 mmol, 3 mL).  The reaction mixture was refluxed for 30 
min.  After solvent evaporation, water (15 mL) was added to the residue.  The mixture 
was extracted with ether (30 mL).  The organic layer was washed with brine and dried over 
anhydrous MgSO4.  The solution was concentrated under reduced pressure.  The crude 
product was subjected to flash column chromatography on silica-gel. 
 
4.3.1.  2-Benzyloxyiminocyclohexanone (1R,2R)-1,2-dimethylethylene acetal (9) 
Colorless oil; (2.51 g, 85%): [α]D22 −24.2 (c 0.33, CHCl3) ; IR (neat): 2970, 2935, 2865, 
1496, 1454 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.13 (3H, d, J = 5.6), 1.23 (3H, d, J = 5.6), 
1.62-1.52 (2H, m), 1.70-1.76 (2H, m), 1.85-1.90 (2H, m), 2.56 (1H, ddd, J = 14.0, 7.4, 5.5), 
2.67 (1H, ddd, J = 14.0, 7.4, 5.5), 3.6 (1H, dq, J = 8.9, 5.6), 3.63 (1H, dq, J = 8.9, 5.6), 5.14 
(2H, dd, J = 14.0, 12.0), 7.27-7.34 (5H, m); 13CNMR (100 MHz, CDCl3) δ 16.4, 16.7, 22.8, 
24.1, 24.9, 38.5, 75.6, 78.0, 79.2, 105.5, 127.5, 128.0, 138.3, 158.7; HRMS (FAB) calcd for 
C17H23NO3 [M + H]+ 290.1757, found 290.1763. 
 
4.3.2.  2-Benzyloxyiminocyclohexanone (1S,2S)-1,2-dimethoxyethylene acetal (10) 
Colorless oil; (2.73 g, 76%): [α]D25 −18.0 (c 1.00, CHCl3); IR (neat): 3030, 2934 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 1.53-1.61 (2H, m), 1.72-1.78 (2H, m), 1.88-1.91 (2H, m), 
2.53-2.62 (1H, m), 2.64-2.73 (1H, m), 3.16 (1H, dd, J = 10.0, 5.0), 3.34-3.41 (1H, m), 3.26 
(3H, s), 3.38 (3H, s), 3.51 (2H, d, J = 4.4), 3.90-3.96 (2H, m), 5.13 (2H, dd, J = 14.8, 11.8), 
7.26-7.37 (5H, m); 13CNMR (100 MHz, CDCl3) δ 22.8, 24.0, 24.9, 38.3, 59.2, 59.4, 72.8, 
73.6, 75.5, 78.0, 78.1, 107.2, 127.6, 128.0, 128.3, 138.5, 158.5; HRMS (FAB) calcd for 
C19H27NO5 [M + H]+ 350.1968, found 350.1977. 
 
4.4  Typical 1,2-additon reaction of PhLi to chiral α-ketoxime-ether acetals  
 
To a stirred solution of chiral α-ketoxime-ether acetal 9 (0.98 mmol, 283 mg) in toluene (5 
mL) was PhLi (2.94 mmol) at −78ºC.  The solution was stirred for 1 h at −78ºC and then 
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was allowed to warm to −17ºC.  After stirring for 1 h, the reaction mixture was quenched 
by the addition of sat. NaHCO3 (aq) (5 mL) at −7ºC.  The reaction mixture was extracted 
with Et2O (10 mL).  The combined organic layers were dried over anhydrous K2CO3.  
After evaporation of the solvent, the resulting residue was purified by silica-gel column 
chromatography to give a mixture of 11 (305 mg, 83% yield).  The diastereoselectivity of 
11 was determined to be 82% de by using the relative methyl doublet signals (7.25 (major) 
and 8.23 (minor) ppm) in its 1H NMR spectrum.  The isomers were separated by silica-gel 
column chromatography.  The major isomer was recrystallized from n-hexane to afford the 
fine crystals (mp 78ºC), adequate for X-ray study. 
 
4.4.1.  (2R)-2-Benzyloxyamino-2-phenylcyclohexanone (1R,2R)-1,2-dimethylethylene 
acetal ((R,R,R)-11) 
Colorless crystals; Mp 78 ºC (n-hexane): [α]D23 24.5 (c 2.00, CHCl3); IR (KBr) 2950, 2927, 
2898, 2859, 1496, 1445 cm-1; 1H NMR (400 MHz, CDCl3) δ 0.72 (3H, d, J = 6.5), 0.91 (3H, 
d, J = 6.5), 1.43 (1H, d, J = 12.8), 1.53-1.70 (3H, m), 1.92 (1H, tq, J = 12.7, 3.1), 2.03 (1H, 
dt, J = 12.7, 5.7), 2.15-2.24 (1H, m), 2.25-2.27 (2H, m), 3.34 (1H, dq, J = 8.6, 5.7), 4.74 (2H, 
dd, J = 20.8, 11.5), 7.20-7.34 (8H, m), 6.46 (1H, m), 7.50-7.52 (2H, m); 13CNMR (100 MHz, 
CDCl3) δ 15.3, 16.9, 20.7, 23.8, 29.5, 33.7, 68.6, 76.3, 77.3, 78.7, 108.6, 126.3, 126.9, 127.4, 
128.1, 128.2, 128.8, 138.6, 140.8; HRMS (FAB) calcd for C23H29NO3 [M + H]+ 368.2227, 
found 368.2231. 
 
4.4.2.  (2S)-2-Benzyloxyamino-2-phenylcyclohexanone (1S,2S)-1,2-dimethoxyethylene 
acetal ((S,S,S)-13)   
Colorless paste: IR (KBr) 2928, 1497, 1454 cm-1; 1H NMR (400 MHz, CDCl3) δ 1.51-1.54 
(2H, m), 1.69 (2H, brs), 1.86-1.91 (1H, m), 1.86-1.91 (1H, m), 1.98-2.01 (1H, m), 2.22-2.25 
(1H, m), 2.29-2.36 (1H, m), 2.70 (2H, brs), 2.74-2.78 (1H, m), 3.21 (3H, s), 3.24-3.30 (2H, 
m), 3.28 (3H, s), 3.72-3.75 (1H, m), 4.70 (2H, dd, J = 22.0, 13.0), 6.46 (1H, s), 7.23-7.38 
(8H, m), 7.51 (2H, d, J = 8.0); 13C NMR (100 MHz, CDCl3) δ 20.7, 23.7, 29.4, 33.8, 59.1, 
59.3, 68.6, 72.8, 73.3, 76.3, 77.1, 78.8, 111.6, 126.5, 127.0, 127.1, 127.3, 127.4, 128.2, 
138.6, 140.9; HRMS (FAB) calcd for C25H33NO5 [M + H]+ 428.2438, found 428.2431. 
 
4.5.  (2R)-2-Benzyloxyamino-2-phenylcyclohexanone (12) from deacetalization of 
(R,R,R)-11 
 
To a stirred solution of (R,R,R)-11 (100 mg, 0.27 mmol) in MeOH (3.6 mL) was added 36% 
HCl (aq) (5.7 mL).  The solution was stirred at 50 ºC overnight.  After solvent 
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evaporation, the resulting mixture was extracted with ether (10 mL).  The organic layer 
was washed with sat. K2CO3 (aq) (3 mL) and dried over anhydrous Na2SO4.  The crude 
was purified by flash column chromatography on silica-gel to give 12 (271 mg, 92% yield).  
Colorless oil: [α]D23 −163.0 (c 2.00, CHCl3); IR (neat) 2943, 2864 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 1.72 (2H, m), 1.84 (1H, m), 1.94 (1H, m), 2.29 (2H, m), 2.49 (1H, m), 2.75 (1H, 
ddd, J = 14.4, 5.6, 3.2), 4.59 (2H, s), 6.35 (1H, s), 7.40-7.24 (10H, m); 13C NMR (100 MHz, 
CDCl3) δ 21.8, 26.9, 32.9, 40.5, 73.8, 77.2, 127.5, 127.6, 128.2, 128.3, 128.4, 128.9, 136.8, 
137.7, 210.7; HRMS (FAB) calcd for C19H21NO2 [M + H]+ 296.1651, found 296.1650. 
 
4.6.  Ethyl (2-chlorobenzoyl)(4-cyanobutyl)acetate (15) 
 
Ethyl (2-chlorobenzoyl)acetate 14 (3.20 g, 14.1 mmol), [IR (film) 2982, 1741, 1687 cm-1; 
1H NMR (400 MHz, CDCl3) δ 1.24-1.27 (3H, t, J = 7.7), 4.00 (2H, s), 4.19-4.25 (2H, q, J = 
7.7), 7.47-7.96 (5H, m)], was added dropwise to a stirred THF (60 mL) slurry of NaH (408 
mg, 17.0 mmol) at 0 ºC.  To the resulting solution were added 5-bromovaleronitrile (2.12 
mL, 18.3 mmol) and solid NaI (417 mg, 2.8 mmol) and then the reaction mixture was heated 
at reflux.  After 24 h, the reaction was allowed to cool, a saturated aqueous NH4Cl solution 
(20 mL) was added.  The organic layer was separated and the aqueous layer was extracted 
with AcOEt (20 mL x3).  The combined organic layers were dried (Na2SO4).  After 
concentration of the solvent under reduced pressure, the residue was purified by flash 
chromatography on silica-gel (20% AcOEt/hexane) to afford ketoester 15 (3.69 g, 85%).  
IR (film) 2245, 1736, 1702 cm-1; 1H NMR (CDCl3): δ 1.16 (keto: 3H, t, J = 6.8), 1.37 (enol: 
3H, t, J = 6.8), 1.45-1.60 (m), 1.69-1.74 (m), 1.98-2.04 (m), 2.16 (enol: 2H, t, J = 7.2), 2.36 
(keto: 2H, t, J = 7.2), 4.13 (keto: 2H, q, J = 6.8), 4.27 (enol: 1H, t, J = 6.8), 4.34 (enol: 2H, q, 
J = 6.8) 7.30-7.50 (4H, m).  13C NMR (CDCl3): δ Keto form: 13.8, 16.8, 25.1, 26.4, 27.3, 
57.3, 61.4, 119.3, 126.8, 129.2, 130.3, 130.5, 132.1, 138.1, 173.0, 197.6; Enol form: 14.1, 
16.6, 24.6, 25.5, 28.3, 60.9, 102.4, 119.4, 126.7, 129.6, 129.8, 130.8, 132.0, 133.9, 168.6, 
168.9. 
 
4.7.  2-Chlorophenyl 5-cyanopentyl ketone (16)  
 
An aqueous NaOH (2 M, 14 mL) solution was added to an ethanolic solution (5 mL) of 15 
(5.49 g, 17.8 mmol).  The reaction mixture was heated at 80 ºC for 12 h.  The resulting 
solution was acidified at 0 ºC by 1 M HCl until a pH of 2.  The organic layer was separated, 
the aqueous layer was extracted with EtOAc (10 mL x3).  The combined organic layers 
were dried (MgSO4) and concentrated under reduced pressure.  The residue was purified 
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by flash chromatography on silica-gel (10% EtOAc/hexane) to afford cyanoketone 16 (3.19 
g, 76%).  IR (film) 2245, 1699 cm-1; 1H NMR (CDCl3): δ 1.54 (2H, m), 1.74 (4H, oct, J = 
7.0), 2.37 (2H, t, J = 7.0), 2.97 (2H, t, J = 7.0), 7.30-7.45 (4H, m); 13C NMR (CDCl3): δ 
17.0, 23.2, 25.3, 28.1, 119.6, 127.0, 128.7, 130.6, 130.8, 131.7, 139.5, 203.1. 
 
4.8.  1-(2-Chlorophenyl)-2-cyano-1-cyclohexene (17) 
 
Solid t-BuOK (602 mg, 5.37 mmol) was added to a refluxing THF solution of 16 (900 mg, 
4.47 mmol) in THF (200 mL).  After 5 h, the solution was cooled to room temperature.  A 
saturated aqueous NH4Cl (30 mL) was added and the organic layer was separated.   The 
aqueous layer was extracted with ether (30 mL x3).  The combined organic layers were 
dried (MgSO4) and concentrated under reduced pressure.  The residue was purified by 
flash chromatography on silica-gel (20% EtOAc/hexane) to give nitrile 17 (555 mg, 57%).  
IR (film) 2211, 1470, 1431 cm-1; 1H NMR (CDCl3): δ 1.79 (4H, brs), 2.24 (1H, brs), 2.42 
(2H, brs), 2.59 (1H, brs), 7.16-7.22 (1H, m), 7.26-7.34 (2H, m), 7.41-7.50 (1H, m); 13C 
NMR (CDCl3): δ 21.2, 21.5, 27.4, 30.9, 111.0, 118.4, 127.1, 129.1, 129.6, 129.9, 131.6, 
139.2, 154.5; HRMS (FAB) calcd for C13H12NCl [M + H]+ 218.0737, found 218.0726. 
 
4.9.  1-Acetyl-2-(2-chlorophenyl)-1-cyclohexene (18) 
 
To an ethereal solution (1.5 mL) containing magnesium turning (104 mg, 4.31 mmol) was 
added a solution of methyl iodide (335 μL, 5.0 mmol) in Et2O (1.0 mL).  When the 
reaction was complete, dry toluene (4.5 mL) was added.  After the ether solvent was 
evacuated under reduced pressure, nitrile 17 (468 mg, 2.15 mmol) was added.  The 
resulting solution was stirred at 100 ºC.  After cooling, 5 M hydrochloric acid (5 mL) was 
added.  Then, the mixture was stirred at 90 ºC for 12 h.  The separated organic layer was 
washed with a dilute aqueous NaHCO3 solution (5 mL) and dried (MgSO4).  After 
concentrated under reduced pressure, the crude was purified by flash chromatography on 
silica-gel (10% EtOAc/hexane) to give ketone 18 (439 mg, 87%).  IR (film) 1663 cm-1; 1H 
NMR (CDCl3): δ 1.67-1.76 (1H, m), 1.73 (3H, s), 1.98-2.00 (1H, m), 2.10-2.24 (1H, m), 
2.25-2.33 (2H, m), 2.52-2.56 (2H, m), 7.08 (1H, dd, J = 3.1, 5.4), 7.23 (2H, dd, J = 3.1, 5.4), 
7.38 (1H, dd, J = 3.1, 5.4); 13C NMR (CDCl3): δ 21.9, 22.2, 25.7, 29.6, 32.1, 127.2, 128.7, 
129.6, 129.7, 137.8, 141.8, 143.0 (x2), 203.1; HRMS (FAB) calcd for C14H15OCl [M + H]+ 
235.0890, found 235.0883. 
 
4.10.  Major (P,S)- and minor (M,S)-1-[2-(2-chlorophenyl)-1-cyclohexenyl]ethanol 
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((P,S)-19 and (M,S)-19) from (S)-BINAL-H reduction of 18 
 
To a 2.4 M THF solution (2.95 mL, 7.10 mmol) of LiAlH4 at 0 ºC was added dropwise a 
solution of ethanol (330 mg, 7.18 mmol) of THF (3.5 mL).  After stirring for 10 min, a 
solution of (S)-binaphthol (2.07 g, 7.21 mmol) in THF (10 mL) was added and the resulting 
mixture was stirred for 30 min at room temperature.  The reducing agent was cooled to 
−100 ºC.  A solution of ketone 18 (500 mg, 2.14 mmol) in THF (12 mL) was added 
dropwise over a period of 5 min at −100 ºC.  The resulting mixture was stirred for an 
additional 6 h at the temperature and at −78 ºC for 24 h.  After addition of 2 M HCl (20 
mL), the mixture was extracted with ether.  The ligand, (S)-binaphthol, was recovered in a 
quantitative level without lowing the enantiopurity by extracting the ethereal solution with 
5% NaOH (20 mL x3).  The organic layer was dried (MgSO4) and concentrated under 
reduced pressure.  A residual oil was purified by flash chromatography on silica-gel (20% 
AcOEt/hexane) to afford the optically active alcohol 19 (395 mg, 78%).  IR (film) 3301, 
1469, 758 cm-1; 1H NMR (CDCl3): δ 1.12 (minor: 3H, d, J = 6.8), 1.17 (major: 3H, d, J = 
6.8), 1.52 (minor isomer: 1H, s), 1.60 (major isomer: 1H, s), 1.62-1.80 (4H, m), 2.00-2.40 
(4H, m), 4.16 (1H, m), 7.05-7.40 (4H, m); 13C NMR (CDCl3): Two isomers δ 20.0, 20.5, 
21.4, 21.5, 22.5 (x2), 22.8, 23.0, 31.1, 31.3, 67.9 (x2), 126.8, 1269, 127.9 (x2), 129.4, 129.5, 
129.6, 130.3, 131.9, 132.2, 132.8, 133.0, 136.7, 137.2, 141.7, 141.8; HRMS (FAB) calcd for 
C14H17OCl [M + H]+ 237.1047, found 237.1023.  The enantiomeric excess was determined 
to be 97% by HPLC analysis (DAICEL CHIRALPAK IA) after conversion of the alcohol into 
the corresponding benzoate. 
 
4.11.  Major (P,S)- and minor (M,S)-19 from Ru[(R,R)-Ts-DPEN](p-cymene) reduction 
of 18 
 
To an azeotropic (5 : 2) mixture29 of formic acid and triethylamine (1 mL) was added a 
solution of ketone 18 (50 mg, 0.214 mmol) in CH2Cl2 (1 mL).  A solution of 
(R,R)-Ru-[N-(tosyl)-1,2-diphenylethylenediamine](p-cymene) (6.4 mg, 0.011 mmol) in 
CH2Cl2 (1 mL) was added to the mixture at room temperature.  After stirring at 40 ºC for 
15 h, the resulting solution was concentrated under reduced pressure.  The crude product 
was purified by flash chromatography on silica-gel to give the optically active alcohols 19 
(34 mg, 68 %).  The enantiomeric excess was determined to be 77% by HPLC analysis 
after conversion of the alcohol into the corresponding benzoate. 
 
4.12.  (PM,S)-1-(1-Benzoylethyl)-2-(2-chlorophenyl)-1-cyclohexene ((PM,S)-20) 
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To a solution of alcohols 19 (30 mg, 0.127 mmol), obtained from enantioselective reduction, 
in CH2Cl2 (1 mL) was added pyridine (30 μL).  After stirring at room temperature for 15 
min, benzoyl chloride (29 μL, 0.255 mmol) was added to the solution.  The resulting 
solution was sirred for 2 h.  The mixture was quenched with 10% HCl (1 mL) and 
extracted with CH2Cl2 (5 mL).  The organic layer was dried (MgSO4) and concentrated 
under reduced pressure to give benzoates 20 (42 mg, 98%).  Colorless oil: IR (film) 1717, 
1271 cm-1; 1H NMR (CDCl3): δ (minor) 1.32 (3H, d, J = 7.0), (major) 1.33 (3H, d, J = 7.0), 
1.70-1.79 (4H, m), 2.00-2.20 (1H, m), 2.23-2.35 (3H, m), (major) 5.40 (1H, q, J = 7.0), 
(major) 5.42 (1H, q, J = 7.0), 7.18-7.40 (4H, m), 7.43 (2H, t, J = 6.8) 7.53 (1H, q, J = 6.8), 
8.00 (2H, t, J = 6.8); 13C NMR (CDCl3): (major) 
δ 18.3, 22.3, 22.4, 22.7, 30.9, 72.0, 127.0, 128.1, 128.2, 129.3, 129.4, 130.0, 141.1, 165.3.  
(minor) 
δ 19.0, 22.5, 22.8, 23.0, 31.1, 71.4, 126.5, 128.1, 128.2, 129.5, 129.7, 129.9, 141.0, 165.2. 
 
4. 13.  Major (P,S)- and minor (M,S)-1-[2-(2-Chlorophenyl)-1-cyclohexenyl]ethyl 
carbamate ((PM,S)-21) 
 
To a solution of alcohol (MP,S)-19 (170 mg, 0.729 mmol) in CH2Cl2 (4.6 mL) at 0 ºC was 
added trichloroacetyl isocyanate (172 μL, 1.46 mmol) and the reaction mixture was stirred 
at 0 ºC for 15 min.  After stirring at room temperature for 15 min, evaporation of the 
solvent gave a crude material.  The residue was dissolved in an aqueous K2CO3 (811 mg) 
solution in water (2 mL) and MeOH (5 mL).  The reaction mixture was stirred at room 
temperature for 1.5 h.  After extraction with ether (10 mL x3), the combined organic layers 
were washed with brine and dried (MgSO4).  Evaporation of the solvent under reduced 
pressure gave a crude product which was purified by flash chromatography on silica-gel 
(30% AcOEt/hexane) to afford allyl carbamate 21 (195 mg, 96%).  IR (film) 3454, 1734, 
1723 cm-1; 1H NMR (CDCl3): δ 1.19 (3H, d, J = 6.7), 1.68-1.78 (4H, m), 1.99-2.03 (1H, m), 
2.17 (2H, brs), 2.30-2.35 (1H, m), 4.79 (2H, brs), 5.04 (1H, q, J = 6.9), 7.15-7.35 (4H, m); 
only distinguishable methyl doublet 1.21 (3H, d, J = 6.7) of minor diastereomer shows the 
raio (3 : 1) of the atropisomers; 13C NMR (CDCl3):   (major) 
δ 18.3, 22.2, 22.3, 22.6, 30.8, 72.0, 126.8, 128.0, 129.2, 130.1, 132.6, 133.4, 133.5, 141.1, 1
56.3: (minor) 
δ 18.9, 22.4, 22.7, 22.8, 31.0, 71.6, 126.5, 128.0, 129.6, 129.9, 132.4, 133.5, 133.6, 141.0, 1
56.4; HRMS (FAB) calcd for C15H18NO2Cl [M + H]+ 280.1105, found 280.1083. 
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4.14.  (1R,2E)-1-(2-Chlorophenyl)-2-ethylidenecyclohexyl isocyanate ((R)-23) 
 
To a solution of carbamate 23 (100 mg, 0.357mmol), triphenylphosphine (288 mg, 1.10 
mmol), and triethylamine (290 μL, 2.10 mmol) in CH2Cl2 (6 mL) cooled to 0 ºC was added 
a solution of carbon tetrabromine (353 mg, 1.06 mmol) in CH2Cl2 (3.5 mL).  After stirring 
at 0 ºC for 30 min, the reaction mixture was diluted with hexane (20 mL).  The resulting 
reaction mixture was washed with H2O, an aqueous saturated NaHCO3 solution, and dried 
(MgSO4).  Evaporation of the solvent under reduced pressure gave a crude product which 
was purified by flash chromatography on silica-gel (20% AcOEt/hexane) to afford 
isocyanate 23 (92 mg, 98%).  Colorless oil: [α]D19 −116.0 (c 1.00, CHCl3); IR (film) 2256, 
1464, 1431 cm-1; 1H NMR (CDCl3): δ  1.48-1.56 (1H, m), 1.59 (3H, dd, J = 6.5, 1.3), 
1.77-1.88 (4H, m), 2.23-2.29 (1H, m), 2.62-2.76 (2H, m), 5.04 (1H, dq, J = 6.7, 1.9), 7.24 
(1H, dt, J = 7.6, 1.7), 7.30 (1H, dt, J = 7.6, 1.7), 7.37 (1H, dd, J = 7.6, 1.7), 7.73 (1H, dd, J = 
7.6, 1.7); 13C NMR (CDCl3): δ 12.9, 22.6, 24.8, 25.2, 39.0, 69.0, 120.9, 124.7, 126.8, 128.7, 
129.2, 131.9, 132.8, 137.3, 140.1; HRMS (FAB) calcd for C15H16NOCl [M + H]+ 262.1000, 
found 262.9987. 
 
4.15.  (R)-1-(2-Chlorophenyl)-2-ethylidene-1-methylaminocyclohexane ((R)-24) 
 
To a slurry of large excess LiAlH4 (50 mg, 1.31 mmol) in THF (1 mL) was added dropwise 
a solution of isocyanate 23 (150 mg, 0.57 mmol) in THF (1 mL).  The resulting solution 
was stirred at room temperature for 1 h and then reflux for 30 mn.  After cooling, a 30% 
NaOH solution (1 mL) was added and the mixture was heated to 90 ºC for 1 h.  The 
reaction mixture was extracted with ether (10 mL x3).  The combined organic layers were 
washed with brine and dried (Na2SO4).  Concentration under reduced pressure gave a 
residue, which was purified by flash chromatography to afford the corresponding methyl 
amine 24 (131 mg, 92%).  Colorless liquid: [α]D20 −48.8 (c 1.67, CHCl3); IR (film) 1427, 
1039, 753 cm-1; 1H NMR (CDCl3): δ 1.46-1.50 (1H, m), 1.59 (3H, d, J = 6.2), 1.60-1.83 (4H, 
m), 1.96 (1H, brs), 2.05 (3H,s), 2.27-2.40 (3H, m), 4.99 (1H, q, J = 6.9), 7.16 (1H, dt, J = 
7.7, 1.7), 7.25 (1H, dt, J = 7.7, 1.7), 7.32 (1H, dd, J = 7.7, 1.7), 7.51 (1H, dd, J = 7.7, 1.7), ; 
13C NMR (CDCl3): δ 12.7, 22.5, 25.3, 26.9, 29.3, 36.4, 65.6, 118.1, 126.4, 127.5, 130.4, 
131.7, 133.9, 139.7, 141.7; HRMS (FAB) calcd for C15H20NCl [M + H]+ 250.1364, found 
250.1366. 
 
4.16.  (S)-Ketamine (1) 
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Amine 24 (85 mg, 0.30 mmol) was dissolved in 10% HCl solution (2 mL).  Concentration 
under reduced pressure gave the corresponding amine HCl salt.  Ozone was passed into a 
solution of the amine HCl salt in MeOH (5 mL) at −78 ºC, terminating the ozonolysis upon 
observing the distinctive blue color of ozone.  After purging with nitrogen, dimethyl 
sulfide (400 μL) was added at −78 ºC.  The solution was allowed to warm up to room 
temperature and concentrated under reduced pressure to give the crude material which was 
dissolved in EtOH (2 mL).  When hexane was added, the HCl salt of (S)-1 was 
immediately crystallized: Colorless crystals; Mp 276 ºC (ethanol-n-hexane): [α]D20 +91.7 (c 
2.00, H2O)30; IR (film) 1722, 773 cm-1; 1H NMR (CD3OD): δ 1.69-1.82 (2H, m), 1.90-2.00 
(2H, m), 2.10-2.15 (1H, m), 2.50-2.59 (2H, m), 3.42 (1H, dd, J = 14.2, 2.8), 7.60-7.70 (3H, 
m), 7.97 (1H, d, J = 6.8); 13C NMR (CD3OD): 
δ 22.8, 28.0, 31.0, 37.5, 40.8, 73.7, 129.2, 129.7, 133.2, 133.3, 133.9, 135.8, 208.3.  The 
salt was again dissolved in a 10% NaOH solution (3 mL) and the corresponding amine was 
extracted with ether (10 mL).  After evaporation of the solvent, the amine was purified by 
flash chromatography (50% AcOEt/hexane) to afford (S)-ketamine (68 mg, 95%).  The 
enantiomeric excess was determined to be >99% by HPLC analysis (DAICEL CHIRALCEL 
OD-H column).  Colorless crystals; Mp 122 ºC (n-hexane); [α]D20 −56.3 (c 1.20, EtOH)30; 
IR (film) 3353, 1701, 752 cm-1; 1H NMR (CDCl3): δ 1.72-1.78 (3H, m), 1.82-1.90 (1H, m), 
1.96-2.05 (1H, m), 2.06-2.15 (1H, m), 2.11 (3H, s), 2.44-2.55 (2H, m), 2.76-2.82 (1H, m), 
7.24 (1H, dt, J = 7.5, 1.5), 7.32 (1H, dt, J = 7.5, 1.5), 7.38 (1H, dd, J = 7.5, 1.5), 7.55 (1H, 
dd, J = 7.5, 1.5); 13C NMR (CDCl3): δ 21.7, 28.0, 29.0, 38.5, 39.4, 70.0, 126.5, 128.6, 129.3, 
131.1, 133.6, 137.7, 209.1. 
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